IL-33/ST2 Axis Deficiency Exacerbates Hepatic Pathology by Regulating Treg and Th17 Cells in Murine Schistosomiasis Japonica

References

• LoVerde PT. Schistosomiasis. Adv Exp Med Biol. 2019;1154:45–70.
   PubMed Web of Science ®Google Scholar
• WHO, schistosomiasis fact sheet; 2020. Available from: https://www.who.int/news-room/fact-sheets/detail/schistosomiasis. Accessed October 30, 2021.
   Google Scholar
• Chuah C, Jones MK, Burke ML, McManus DP, Gobert GN. Cellular and chemokine-mediated regulation in schistosome-induced hepatic pathology. Trends Parasitol. 2014;30(3):141–150. doi:10.1016/j.pt.2013.12.009
   PubMed Web of Science ®Google Scholar
• McManus DP, Bergquist R, Cai P, Ranasinghe S, Tebeje BM, You H. Schistosomiasis-from immunopathology to vaccines. Semin Immunopathol. 2020;42(3):355–371. doi:10.1007/s00281-020-00789-x
   PubMed Web of Science ®Google Scholar
• Takaki KK, Rinaldi G, Berriman M, Pagán AJ, Ramakrishnan L. Schistosoma mansoni eggs modulate the timing of granuloma formation to promote transmission. Cell Host Microbe. 2021;29(1):58–67.e5. doi:10.1016/j.chom.2020.10.002
   PubMed Web of Science ®Google Scholar
• Santana JB, de Almeida TVVS, Lopes DM, et al. Phenotypic characterization of CD4+ T lymphocytes in periportal fibrosis secondary to schistosomiasis. Front Immunol. 2021;12:605235. doi:10.3389/fimmu.2021.605235
   PubMed Web of Science ®Google Scholar
• Zhang Y, Xiong DH, Li Y, et al. Schistosoma japonicum infection in treg-specific USP21 knockout mice. J Immunol Res. 2021;2021:6613162. doi:10.1155/2021/6613162
   PubMed Web of Science ®Google Scholar
• Zheng B, Zhang J, Chen H, et al. T lymphocyte-mediated liver immunopathology of schistosomiasis. Front Immunol. 2020;11:61. doi:10.3389/fimmu.2020.00061
   PubMed Web of Science ®Google Scholar
• Angeles JMM, Mercado VJP, Rivera PT. Behind enemy lines: immunomodulatory armamentarium of the schistosome parasite. Front Immunol. 2020;11:1018. doi:10.3389/fimmu.2020.01018
   PubMed Web of Science ®Google Scholar
• Tang CL, Lei JH, Wang T, et al. Effect of CD4+ CD25+ regulatory T cells on the immune evasion of Schistosoma japonicum. Parasitol Res. 2011;108(2):477–480. doi:10.1007/s00436-010-2089-2
   PubMed Web of Science ®Google Scholar
• Herbert DR, Orekov T, Perkins C, Finkelman FD. IL-10 and TGF-beta redundantly protect against severe liver injury and mortality during acute schistosomiasis. J Immunol. 2008;181(10):7214–7220. doi:10.4049/jimmunol.181.10.7214
   PubMed Web of Science ®Google Scholar
• Shrestha S, Yang K, Guy C, Vogel P, Neale G, Chi H. Treg cells require the phosphatase PTEN to restrain TH1 and TFH cell responses. Nat Immunol. 2015;16(2):178–187. doi:10.1038/ni.3076
   PubMed Web of Science ®Google Scholar
• Turner JD, Jenkins GR, Hogg KG, et al. CD4+CD25+ regulatory cells contribute to the regulation of colonic Th2 granulomatous pathology caused by schistosome infection. PLoS Negl Trop Dis. 2011;5(8):e1269. doi:10.1371/journal.pntd.0001269
   PubMed Web of Science ®Google Scholar
• Ahmad SF, Ansari MA, Nadeem A, et al. Dysregulation of the expression of HLA-DR, costimulatory molecule, and chemokine receptors on immune cells in children with autism. Int Immunopharmacol. 2018;65:360–365. doi:10.1016/j.intimp.2018.10.027
   PubMed Web of Science ®Google Scholar
• Ahmad SF, Ansari MA, Nadeem A, et al. Dysregulation of T cell immunoglobulin and mucin domain 3 (TIM-3) signaling in peripheral immune cells is associated with immune dysfunction in autistic children. Mol Immunol. 2019;106:77–86. doi:10.1016/j.molimm.2018.12.020
   PubMed Web of Science ®Google Scholar
• Molofsky AB, Savage AK, Locksley RM. Interleukin-33 in tissue homeostasis, injury, and inflammation. Immunity. 2015;42(6):1005–1019. doi:10.1016/j.immuni.2015.06.006
   PubMed Web of Science ®Google Scholar
• Stanczak MA, Sanin DE, Apostolova P, et al. IL-33 expression in response to SARS-CoV-2 correlates with seropositivity in COVID-19 convalescent individuals. Nat Commun. 2021;12(1):2133. doi:10.1038/s41467-021-22449-w
   PubMed Web of Science ®Google Scholar
• Rostan O, Arshad MI, Piquet-Pellorce C, Robert-Gangneux F, Gangneux JP, Samson M. Crucial and diverse role of the interleukin-33/ST2 axis in infectious diseases. Infect Immun. 2015;83(5):1738–1748. doi:10.1128/IAI.02908-14
   PubMed Web of Science ®Google Scholar
• Biton J, Khaleghparast Athari S, Thiolat A, et al. In vivo expansion of activated Foxp3+ Regulatory T cells and establishment of a type 2 immune response upon IL-33 treatment protect against experimental arthritis. J Immunol. 2016;197(5):1708–1719. doi:10.4049/jimmunol.1502124
   PubMed Web of Science ®Google Scholar
• Yu Y, Deng W, Lei J. Interleukin-33 promotes Th2 immune responses in infected mice with Schistosoma japonicum. Parasitol Res. 2015;114(8):2911–2918. doi:10.1007/s00436-015-4492-1
   PubMed Web of Science ®Google Scholar
• Peng H, Zhang Q, Li X, et al. IL-33 contributes to Schistosoma japonicum-induced hepatic pathology through induction of M2 macrophages. Sci Rep. 2016;6:29844. doi:10.1038/srep29844
   PubMed Web of Science ®Google Scholar
• Mukendi JPK, Nakamura R, Uematsu S, Hamano S. Interleukin (IL)-33 is dispensable for Schistosoma mansoni worm maturation and the maintenance of egg-induced pathology in intestines of infected mice. Parasit Vectors. 2021;14(1):70. doi:10.1186/s13071-020-04561-w
   PubMed Web of Science ®Google Scholar
• Kamdem SD, Konhawa F, Kuemkon EM, et al. Negative association of interleukin-33 plasma levels and schistosomiasis infection in a site of polyparasitism in rural Cameroon. Front Immunol. 2019;10:2827. doi:10.3389/fimmu.2019.02827
   PubMed Web of Science ®Google Scholar
• Wilson S, Jones FM, Fofana HK, et al. A late IL-33 response after exposure to Schistosoma haematobium antigen is associated with an up-regulation of IL-13 in human eosinophils. Parasite Immunol. 2013;35(7–8):224–228. doi:10.1111/pim.12035
   PubMed Web of Science ®Google Scholar
• Wen X, He L, Chi Y, et al. Dynamics of Th17 cells and their role in Schistosoma japonicum infection in C57BL/6 mice. PLoS Negl Trop Dis. 2011;5(11):e1399. doi:10.1371/journal.pntd.0001399
   PubMed Web of Science ®Google Scholar
• Xiao Y, Lai L, Chen H, et al. Interleukin-33 deficiency exacerbated experimental autoimmune encephalomyelitis with an influence on immune cells and glia cells. Mol Immunol. 2018;101:550–563. doi:10.1016/j.molimm.2018.08.026
   PubMed Web of Science ®Google Scholar
• Zhang Z, Zhang N, Shi J, et al. Allograft or recipient ST2 deficiency oppositely affected cardiac allograft vasculopathy via differentially altering immune cells infiltration. Front Immunol. 2021;12:657803. doi:10.3389/fimmu.2021.657803
   PubMed Web of Science ®Google Scholar
• Zhao F, Huang X, Hou X, et al. Schistosoma japonicum: susceptibility of neonate mice born to infected and noninfected mothers following subsequent challenge. Parasite Immunol. 2013;35(5–6):157–163. doi:10.1111/pim.12027
   PubMed Web of Science ®Google Scholar
• Guan F, Zhang C, Jiang C, et al. ApoE deficiency promotes hepatic pathology by aggravating Th17/Treg imbalance in murine schistosomiasis japonica. Parasite Immunol. 2020;42(12):e12785. doi:10.1111/pim.12785
   PubMed Web of Science ®Google Scholar
• Xu L, Li W, Wang X, et al. The IL-33-ST2-MyD88 axis promotes regulatory T cell proliferation in the murine liver. Eur J Immunol. 2018;48(8):1302–1307. doi:10.1002/eji.201747402
   PubMed Web of Science ®Google Scholar
• Kabat AM, Harrison OJ, Riffelmacher T, et al. The autophagy gene Atg16l1 differentially regulates Treg and TH2 cells to control intestinal inflammation. Elife. 2016;5:e12444. doi:10.7554/eLife.12444
   PubMed Web of Science ®Google Scholar
• Guan F, Jiang W, Bai Y, et al. Purinergic P2X7 receptor mediates the elimination of Trichinella spiralis by activating NF-κB/NLRP3/IL-1β pathway in macrophages. Infect Immun. 2021;89(5):e00683–20. doi:10.1128/IAI.00683-20
   PubMed Web of Science ®Google Scholar
• Liew FY, Girard JP, Turnquist HR. Interleukin-33 in health and disease. Nat Rev Immunol. 2016;16(11):676–689. doi:10.1038/nri.2016.95
   PubMed Web of Science ®Google Scholar
• Schiering C, Krausgruber T, Chomka A, et al. The alarmin IL-33 promotes regulatory T-cell function in the intestine. Nature. 2014;513(7519):564–568. doi:10.1038/nature13577
   PubMed Web of Science ®Google Scholar
• Hung LY, Tanaka Y, Herbine K, et al. Cellular context of IL-33 expression dictates impact on anti-helminth immunity. Sci Immunol. 2020;5(53):eabc6259. doi:10.1126/sciimmunol.abc6259
   PubMed Web of Science ®Google Scholar
• Pastille E, Wasmer MH, Adamczyk A, et al. The IL-33/ST2 pathway shapes the regulatory T cell phenotype to promote intestinal cancer. Mucosal Immunol. 2019;12(4):990–1003. doi:10.1038/s41385-019-0176-y
   PubMed Web of Science ®Google Scholar
• Qiu X, Qi C, Li X, Fang D, Fang M. IL-33 deficiency protects mice from DSS-induced experimental colitis by suppressing ILC2 and Th17 cell responses. Inflamm Res. 2020;69(11):1111–1122. doi:10.1007/s00011-020-01384-4
   PubMed Web of Science ®Google Scholar
• Zhu JF, Xu Y, Zhao J, et al. IL-33 protects mice against DSS-induced chronic colitis by increasing both regulatory B cell and regulatory T cell responses as well as decreasing Th17 cell response. J Immunol Res. 2018;2018:1827901. doi:10.1155/2018/1827901
   PubMed Web of Science ®Google Scholar
• Wu MX, Wang SH, Xie Y, et al. Interleukin-33 alleviates diabetic cardiomyopathy through regulation of endoplasmic reticulum stress and autophagy via insulin-like growth factor-binding protein 3. J Cell Physiol. 2021;236(6):4403–4419. doi:10.1002/jcp.30158
   PubMed Web of Science ®Google Scholar
• Wang Z, Wu L, Pan B, Chen Y, Zhang T, Tang N. Interleukin 33 mediates hepatocyte autophagy and innate immune response in the early phase of Acetaminophen-induced acute liver injury. Toxicology. 2021;456:152788. doi:10.1016/j.tox.2021.152788
   PubMed Web of Science ®Google Scholar
• Wang Z, Shi L, Hua S, Qi C, Fang M. IL-33 ameliorates experimental colitis involving regulation of autophagy of macrophages in mice. Cell Biosci. 2019;9:10. doi:10.1186/s13578-019-0271-5
   PubMed Web of Science ®Google Scholar
• Deretic V, Saitoh T, Akira S. Autophagy in infection, inflammation and immunity. Nat Rev Immunol. 2013;13(10):722–737. doi:10.1038/nri3532
   PubMed Web of Science ®Google Scholar
• Jacquin E, Apetoh L. Cell-intrinsic roles for autophagy in modulating CD4 T cell functions. Front Immunol. 2018;9:1023. doi:10.3389/fimmu.2018.01023
   PubMed Web of Science ®Google Scholar
• Bjørkøy G, Lamark T, Pankiv S, Øvervatn A, Brech A, Johansen T. Monitoring autophagic degradation of p62/SQSTM1. Methods Enzymol. 2009;452:181–197.
   PubMed Web of Science ®Google Scholar
• Zhou Z, Yan F, Liu O. Interleukin (IL)-33: an orchestrator of immunity from host defence to tissue homeostasis. Clin Transl Immunol. 2020;9(6):e1146. doi:10.1002/cti2.1146
   PubMed Web of Science ®Google Scholar
• Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family. Nat Rev Immunol. 2010;10(2):103–110. doi:10.1038/nri2692
   PubMed Web of Science ®Google Scholar
• Humphreys NE, Xu D, Hepworth MR, Liew FY, Grencis RK. IL-33, a potent inducer of adaptive immunity to intestinal nematodes. J Immunol. 2008;180(4):2443–2449. doi:10.4049/jimmunol.180.4.2443
   PubMed Web of Science ®Google Scholar
• Peng H, Sun R, Zhang Q, et al. Interleukin 33 mediates type 2 immunity and inflammation in the central nervous system of mice infected with Angiostrongylus cantonensis. J Infect Dis. 2013;207(5):860–869. doi:10.1093/infdis/jis682
   PubMed Web of Science ®Google Scholar
• Rostan O, Gangneux JP, Piquet-Pellorce C, et al. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani. mBio. 2013;4(5):e00383–13. doi:10.1128/mBio.00383-13
   PubMed Web of Science ®Google Scholar
• Chen RQ, Zhou YB, Jiang LF, et al. Correlation between acute schistosomiasis japonica and serum interleukin-33 levels. Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi. 2012;24(1):32–34, 39.
   PubMedGoogle Scholar
• Li ZY, Xiao L, Lin G, et al. Contribution of tissue transglutaminase to the severity of hepatic fibrosis resulting from Schistosoma japonicum infection through the regulation of IL-33/ST2 expression. Parasit Vectors. 2019;12(1):302. doi:10.1186/s13071-019-3542-4
   PubMedGoogle Scholar
• Alvarez F, Fritz JH, Piccirillo CA. Pleiotropic effects of IL-33 on CD4(+) T cell differentiation and effector functions. Front Immunol. 2019;10:522. doi:10.3389/fimmu.2019.00522
   PubMed Web of Science ®Google Scholar
• Hung LY, Lewkowich IP, Dawson LA, et al. IL-33 drives biphasic IL-13 production for noncanonical Type 2 immunity against hookworms. Proc Natl Acad Sci U S A. 2013;110(1):282–287. doi:10.1073/pnas.1206587110
   PubMed Web of Science ®Google Scholar
• Clark JT, Christian DA, Gullicksrud JA, et al. IL-33 promotes innate lymphoid cell-dependent IFN-γ production required for innate immunity to Toxoplasma gondii. Elife. 2021;10:e65614. doi:10.7554/eLife.65614
   PubMed Web of Science ®Google Scholar
• Cao S, Zhu L, Zhu C, et al. Helicobacter hepaticus infection-induced IL-33 promotes hepatic inflammation and fibrosis through ST2 signaling pathways in BALB/c mice. Biochem Biophys Res Commun. 2020;525(3):654–661. doi:10.1016/j.bbrc.2020.02.139
   PubMed Web of Science ®Google Scholar
• Maggi L, Rocha IC, Camelo GMA, Fernandes VR, Negrão-Corrêa D. The IL-33/ST2 pathway is not essential to Th2 stimulation but is key for modulation and survival during chronic infection with Schistosoma mansoni in mice. Cytokine. 2021;138:155390. doi:10.1016/j.cyto.2020.155390
   PubMed Web of Science ®Google Scholar
• Barbier L, Ferhat M, Salamé E, et al. Interleukin-1 family cytokines: keystones in liver inflammatory diseases. Front Immunol. 2019;10:2014. doi:10.3389/fimmu.2019.02014
   PubMed Web of Science ®Google Scholar
• Fairfax KC, Amiel E, King IL, Freitas TC, Mohrs M, Pearce EJ. IL-10R blockade during chronic schistosomiasis mansoni results in the loss of B cells from the liver and the development of severe pulmonary disease. PLoS Pathog. 2012;8(1):e1002490. doi:10.1371/journal.ppat.1002490
   PubMed Web of Science ®Google Scholar
• Ondigo BN, Ndombi EM, Nicholson SC, et al. Functional studies of T regulatory lymphocytes in human schistosomiasis in Western Kenya. Am J Trop Med Hyg. 2018;98(6):1770–1781. doi:10.4269/ajtmh.17-0966
   PubMed Web of Science ®Google Scholar
• Kong H, He J, Guo S, et al. Endothelin receptors promote schistosomiasis-induced hepatic fibrosis via splenic B cells. PLoS Pathog. 2020;16(10):e1008947. doi:10.1371/journal.ppat.1008947
   PubMed Web of Science ®Google Scholar
• Faustino LD, Griffith JW, Rahimi RA, et al. Interleukin-33 activates regulatory T cells to suppress innate gammadelta T cell responses in the lung. Nat Immunol. 2020;21(11):1371–1383. doi:10.1038/s41590-020-0785-3
   PubMed Web of Science ®Google Scholar
• Kawai K, Uchiyama M, Hester J, Issa F. IL-33 drives the production of mouse regulatory T cells with enhanced in vivo suppressive activity in skin transplantation. Am J Transplant. 2021;21(3):978–992. doi:10.1111/ajt.16266
   PubMed Web of Science ®Google Scholar
• Liu Q, Turnquist HR. Controlling the burn and fueling the fire: defining the role for the alarmin interleukin-33 in alloimmunity. Curr Opin Organ Transplant. 2016;21(1):45–52. doi:10.1097/MOT.0000000000000265
   PubMed Web of Science ®Google Scholar
• Zhou S, Qi Q, Wang X, et al. SjHSP60 induces CD4+ CD25+ Foxp3+ Tregs via TLR4-Mal-drived production of TGF-β in macrophages. Immunol Cell Biol. 2018;96(9):958–968. doi:10.1111/imcb.12160
   PubMed Web of Science ®Google Scholar
• Terraza C, Fuentes R, Pino-Lagos K. IFN-gamma and IL-33 modulate mesenchymal stem cells function targeting Th1/Th17 axis in a murine skin transplantation model. Cytokine. 2018;111:317–324. doi:10.1016/j.cyto.2018.09.013
   PubMed Web of Science ®Google Scholar
• Jiang HR, Milovanović M, Allan D, et al. IL-33 attenuates EAE by suppressing IL-17 and IFN-gamma production and inducing alternatively activated macrophages. Eur J Immunol. 2012;42(7):1804–1814. doi:10.1002/eji.201141947
   PubMed Web of Science ®Google Scholar
• Zhou W, Yang Y, Mei C, et al. Inhibition of rho-kinase downregulates Th17 cells and ameliorates hepatic fibrosis by Schistosoma japonicum infection. Cells. 2019;8(10):1262. doi:10.3390/cells8101262
   PubMed Web of Science ®Google Scholar
• Leal-Silva T, Vieira-Santos F, Oliveira FMS, et al. Detrimental role of IL-33/ST2 pathway sustaining a chronic eosinophil-dependent Th2 inflammatory response, tissue damage and parasite burden during Toxocara canis infection in mice. PLoS Negl Trop Dis. 2021;15(7):e0009639. doi:10.1371/journal.pntd.0009639
   PubMed Web of Science ®Google Scholar
• Bakheet SA, Ansari MA, Nadeem A, et al. CXCR3 antagonist AMG487 suppresses rheumatoid arthritis pathogenesis and progression by shifting the Th17/Treg cell balance. Cell Signal. 2019;64:109395. doi:10.1016/j.cellsig.2019.109395
   PubMed Web of Science ®Google Scholar
• Zhang W, Liu X, Zhu Y, et al. Transcriptional and posttranslational regulation of Th17/Treg balance in health and disease. Eur J Immunol. 2021;51(9):2137–2150. doi:10.1002/eji.202048794
   PubMed Web of Science ®Google Scholar
• Wang L, Das JK, Kumar A, et al. Autophagy in T-cell differentiation, survival and memory. Immunol Cell Biol. 2021;99(4):351–360. doi:10.1111/imcb.12422
   PubMed Web of Science ®Google Scholar
• Zhang J, Chen L, Xiong F, et al. Autophagy in regulatory T cells: a double-edged sword in disease settings. Mol Immunol. 2019;109:43–50. doi:10.1016/j.molimm.2019.02.004
   PubMed Web of Science ®Google Scholar
• An N, Chen Y, Wang C, et al. Chloroquine autophagic inhibition rebalances Th17/Treg-mediated immunity and ameliorates systemic lupus erythematosus. Cell Physiol Biochem. 2017;44(1):412–422. doi:10.1159/000484955
   PubMedGoogle Scholar
• Cheng LS, Li J, Liu Y, et al. HMGB1-induced autophagy: a new pathway to maintain Treg function during chronic hepatitis B virus infection. Clin Sci (Lond). 2017;131(5):381–394. doi:10.1042/CS20160704
   PubMed Web of Science ®Google Scholar
• Zhu J, Zhang W, Zhang L, et al. IL-7 suppresses macrophage autophagy and promotes liver pathology in Schistosoma japonicum-infected mice. J Cell Mol Med. 2018;22(7):3353–3363. doi:10.1111/jcmm.13610
   PubMed Web of Science ®Google Scholar